Search Results - "токсическая энцефалопатия"

1

Academic Journal

Нейротоксическое действие этанола и других психоактивных веществ как общепатологическое основание токсической энцефалопатии

Authors: Al’bina Z. Pavlova, Roman A. Kalekin, Pavel G. Dzhuvalyakov, Alla A. Volkova, Andrey L. Pavlov

Source: Журнал медико-биологических исследований, Vol 11, Iss 2, Pp 207-216 (2023)

Subject Terms: алкоголь, психоактивные вещества, нейроны головного мозга, микроциркуляторное русло, токсическая энцефалопатия, хроническая алкогольная интоксикация, сочетанная (комбиниро- ванная) интоксикация, танатогенез, Sports medicine, RC1200-1245, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://journals.narfu.ru/index.php/med/article/view/1152; https://doaj.org/toc/2542-1298; https://doaj.org/toc/2687-1491

Access URL: https://doaj.org/article/76e39235c72941c798e69112a19dfb56

View record in DOAJ

2

Academic Journal

Neurotoxic Complications of Chemotherapy in Children. Literature Review ; Нейротоксические осложнения химиотерапии у детей. Обзор литературы

Authors: Olga P. Kovtun, Vladimir V. Bazarny, Oksana V. Koryakina, Alexandr N. Abdullaev, О. П. Ковтун, В. В. Базарный, О. В. Корякина, А. Н. Абдуллаев

Contributors: Not specified, Не указан

Source: Pediatric pharmacology; Том 17, № 1 (2020); 12-17 ; Педиатрическая фармакология; Том 17, № 1 (2020); 12-17 ; 2500-3089 ; 1727-5776

Subject Terms: литературный обзор, toxic encephalopathy, peripheral neuropathy, review, токсическая энцефалопатия, периферическая полинейропатия

File Description: application/pdf

Relation: https://www.pedpharma.ru/jour/article/view/1809/1122; Lemiere J, Vercruysse T, Jacobs S, et al. Follow-up study of intellectual functioning in children treated for a brain tumor. Pediatric Blood Cancer. 2014;61(S2):S282-S282.; Sioka C, Kyritsis AP. Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol. 2009;63(5):761-767. doi:10.1007/s00280-008-0876-6.; Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer. 2007;7(3):192-201.; Lofstad GE, Reinfjell T, Hestad K, Diseth TH. Cognitive outcome in children and adolescents treated for acute lymphoblastic leukaemia with chemotherapy only. Acta Paediatr. 2009; 98(1):180-186. doi:10.1111/j.1651-2227.2008.01055.x.; Stouten-Kemperman MM, de Ruiter MB, Caan MW, et al. Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy. Hum Brain Mapp. 2015;36:4638-4647. doi:10.1002/hbm.22942.; Кузнецова Е.И. Нейротоксическое влияние химиотерапии на функции ЦНС у детей с лимфоидными опухолями // Патологическая физиология и экспериментальная терапия. — 2014. — Т.58. — №4. — С. 71-77. doi:10.25557/0031-2991.2014.04.71-77.; Mohrmann C, Henry J, Hauff M, Hayashi RJ. Neurocognitive outcomes and school performance in solid tumor cancer survivors lacking therapy to the central nervous system. J Pers Med. 2015;5(2):83-90. doi:10.3390/jpm5020083.; Duffner PK. The long term effects of chemotherapy on the central nervous system. J Biol. 2006;5(7):21. doi:10.1186/jbiol51.; Политова Е.А., Румянцев А.Г., Заваденко Н.Н., и др. Нервномышечные осложнения при терапии острого миелобластного лейкоза // Вопросы практической педиатрии. — 2015. — Т.10. — №4. — С. 15-19.; Kelley KW, Bluthe RM, Dantzer R, et al. Cytokine-induced sickness behavior. Brain Behav Immun. 2003;17(1):S112-118. doi:10.1016/s0889-1591(02)00077-6.; Yang M, Kim JS, Kim J, et al. Neurotoxicity of methotrexate to hippocampal cells in vivo and in vitro. Biochem Pharmacol. 2011;82(1):72-80. doi:10.1016/j.bcp.2011.03.020.; Christie LA, Acharya MM, Parihar VK, et al. Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clin Cancer Res. 2012;18(7):1954-1965. doi:10.1158/1078-0432.CCR-11-2000.; Rzeski W, Pruskil S, Macke A, et al. Anticance1r agents are potent neurotoxins in vitro and in vivo. Ann Neurol. 2004;56(3):351-360. doi:10.1002/ana.20185.; Wefel JS, Witgert ME, Meyers CA. Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev. 2008;18(2):121-131. doi:10.1007/s11065-008-9058-x.; Yan F, Liu JJ, Ip V, et al. Role of platinum DNA damage-induced transcriptional inhibition in chemotherapy-induced neuronal atrophy and peripheral neurotoxicity. J Neurochem. 2015;135(6):1099-1112. doi:10.1111/jnc.13355.; Kim HS, Guo C, Thompson EL, et al. APE1, the DNA base excision repair protein, regulates the removal of platinum adducts in sensory neuronal cultures by NER. Mutat Res. 2015;779:96-104. doi:10.1016/j.mrfmmm.2015.06.010.; Calls A, Carozzi V, Navarro X, et al. Pathogenesis of platinum-induced peripheral neurotoxicity: insights from preclinical studies. Exp Neurol. 2020;325:113141. doi:10.1016/j.expneu-rol.2019.113141.; Adamson P Blaney S, Helman L, et al. Principles and practice of pediatric oncology. 6th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health; 2011.; Granowetter L, Rosenstock JG, Packer RJ. Enhanced cis-platinum neurotoxicity in pediatric patients with brain tumors. J Neurooncol. 1983;1(4):293-297. doi:10.1007/BF00165711.; Van As JW, van den Berg H, van Dalen EC. Platinum-induced hearing loss after treatment for childhood cancer. Cochrane Database Syst Rev. 2016;(8):CD010181. doi:10.1002/14651858.CD010181.pub2.; Bertolini P Lassalle M, Mercier G, et al. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss. J Pediatr Hematol Oncol. 2004 ;26(10):649-655.; Dean JB, Hayashi SS, Albert CM, et al. Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens. J Pediatr Hematol Oncol. 2008;30(2):130-134. doi:10.1097/MPH.0b013e31815d1d83.; Hodgson KD, Hutchinson AD, Wilson CJ, Nettelbeck T. A metaanalysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev. 2013;39(3):297-304.; Gomber S, Dewan P Chhonker D. Vincristine induced neurotoxicity in cancer patients. Indian J Pediatr. 2010;77(1):97-100. doi:10.1007/s12098-009-0254-3.; Arzanian MT, Mehdizadeh M, Zamani GR. Vincristine induced neurotoxicity: study of 75 cases. Iran J Child Neur. 2009;3(2):39-44.; Guram S, Richards E, Messahel B. G21(P) Investigating vincristine neurotoxicity in paediatric haematology/oncology patients: a role for genotyping. Arch Dis Child. 2016;101:A15. doi:10.1136/archdischild-2016-310863.21.; Renbarger JL, McCammack KC, Rouse CE, Hall SD. Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients. Pediatr Blood Cancer. 2008;50:769-771. doi:10.1002/pbc.21435.; Sims RP The effect of race on the CYP3A-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia. J Oncol Pharm Pract. 2016;22(1):76-81. doi:10.1177/1078155214553143.; Adhikari S, Dongol RM, Hewett Y, Shah BK. Vincristine-induced blindness: a case report and review of literature. Anticanc Res. 2014;(11):6731-6733.; Totadri S, Trehan A. Vincristine induced cortical blindness: an alarming but reversible side effect. Pediatr Hematol Oncol J. 2016;1(3):61-62. doi:10.1016/j.phoj.2016.11.001.; Рощик А.С., Колесникова О.И. Высокие дозы метотрексата и система гемостаза у детей с острым лимфобластным лейкозом // Международный журнал прикладных и фундаментальных исследований. — 2014. — №1-2. — С. 287-287.; Вильчевская Е.В. Токсическое действие средних доз метотрексата при лечении детей, больных острым лимфобластным лейкозом // Онкология. — 2002. — №4. — С. 212-214.; Bhojwani D, Sabin ND, Pei D, et al. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol. 2014;32(9):949-959. doi:10.1200/JC0.2013.53.0808.; Youssef AA, Raafat TA, Madney Y. Child with acute methotrexate related neurotoxicity: Can diffusion weighted MRI help? Egypt J Radiol Nucl Med. 2015;46(4):1149-1153. doi:10.1016/j.ejrnm.2015.07.015.; Fisher MJ, Khademian ZP Simon EM. et al. Diffusion-weighted mr imaging of early methotrexate-related neurotoxicity in children. Am J Neur. 2005;26(7):1686-1689.; Di Cataldo A, Astuto M, Rizzo G, et al. Neurotoxicity during ifos-famide treatment in children. Med Sci Monit. 2009;15(1):CS22-25.; Lane S, Wilson S. Ifosfamide — induced encephalopathy (guide). TVCN Principal Treatment Centre Children's Hospital Oxford; 2015. Avaliable from: http://tvscn.nhs.uk/wp-content/uploads/2014/09/Cancer-Children-Haematology-Emergencies-Ifosfamide-Induced-Encephalopathy-v3.0-Dec-2015.pdf.; Nicolao P Giometto B. Neurological toxicity of ifosfamide. Oncology. 2003;65(Suppl 2):11-16.; Tran PN, Kong XT. Cytarabine induced acute cerebellar syndrome during hyper-CVAD treatment for B-cell acute lymphoblastic leukemia. Case Rep Neurol. 2017;9(1):114-120. doi:10.1159/000468921.; Dotson JL, Jamil MO. Successful treatment of cytarabine-related neurotoxicity with corticosteroids, a case series. Int J Hematol. 2018;108(5):554-557. doi:10.1007/s12185-018-2485-4.; Stone JB, De Angelis LM. Cancer treatment-induced neurotoxicity:a focus on newer treatments. Nature Rev Clin Oncol. 2016;13(2):92-105. doi:10.1038/nrclinonc.2015.152.; Sainz de la Maza Cantero S, Jimenez Martin A, de Felipe Mimbrera A, Corral Corral I. Cerebellar toxicity due to cytarabine: a series of 4 cases. Neurologia. 2016;31(7):491-492. doi:10.1016/j.nrl.2014.12.017.; Varghese DR, Joseph D, Prabhu R, Anila KN. High dose cytarabine associated cerebellar toxicity: a case report. Natl J Physiol Pharm Pharmacol. 2018;8(1):142-143.; Pellier I, Leboucher B, Rachieru P et al. Flushing out of cerebrospinal fluid as a therapy for acute cerebellar dysfunction caused by high dose of cytosine arabinoside: a case report. J Pediatr Hematol Oncol. 2006;28(12):837-839. doi:10.1097/MPH.0b013e31802d3e2d.; Lowenberg B. Sense and nonsense of high-dose cytarabine for acute myeloid leukemia. Blood. 2013;121(1):26-28. doi:10.1182/blood-2012-07-444851.; Malhotra P Mahi S, Lal V, et al. Cytarabine-induced neurotoxicity responding to methyl prednisolone. Am J Hematol. 2004;77(4):416. doi:10.1002/ajh.20171.; Ibrahim EY, Ehrlich BE. Prevention of chemotherapy-induced peripheral neuropathy: a review of recent findings. Crit Rev Oncol Hematol. 2020;145:102831. doi:10.1016/j.critrev-onc.2019.102831.; https://www.pedpharma.ru/jour/article/view/1809

Availability: https://www.pedpharma.ru/jour/article/view/1809
https://doi.org/10.15690/pf.v17i1.2077

View record from BASE

3

Academic Journal